BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32464489)

  • 21. The Neurostimulation of the Brain in Depression Trial: Protocol for a Randomized Controlled Trial of Transcranial Direct Current Stimulation in Treatment-Resistant Depression.
    Suleman R; Tucker BV; Dursun SM; Demas ML
    JMIR Res Protoc; 2021 Mar; 10(3):e22805. PubMed ID: 33729165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of non-BDNF neurotrophins and GDNF levels after depression treatment with sertraline and transcranial direct current stimulation in a factorial, randomized, sham-controlled trial (SELECT-TDCS): an exploratory analysis.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jan; 56():91-6. PubMed ID: 25172025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcranial direct current stimulation: A novel approach in the treatment of vascular depression.
    Zanardi R; Poletti S; Prestifilippo D; Attanasio F; Barbini B; Colombo C
    Brain Stimul; 2020; 13(6):1559-1565. PubMed ID: 32896644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bifrontal-transcranial direct current stimulation as an early augmentation strategy in major depressive disorder: A single-blind randomised controlled trial.
    Kumari B; Singh A; Kar SK; Tripathi A; Agarwal V
    Asian J Psychiatr; 2023 Aug; 86():103637. PubMed ID: 37270874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concomitant Transcranial Direct Current Stimulation With Ultrabrief Electroconvulsive Therapy: A 2-Week Double-Blind Randomized Sham-Controlled Trial.
    Mayur P; Howari R; Byth K; Vannitamby R
    J ECT; 2018 Dec; 34(4):291-295. PubMed ID: 29369074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertraline versus escitalopram in South Asians with moderate to severe major depressive disorder: (SOUTH-DEP) a double-blind, parallel, randomized controlled trial.
    Raza S; Ahmed S; Islam R; Ahmed M; Ashraf S; Islam H; Kiyani H; Saqib M; Shah SAR; Mumtaz H
    Ann Med Surg (Lond); 2023 Oct; 85(10):4851-4859. PubMed ID: 37811114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential improvement in depressive symptoms for tDCS alone and combined with pharmacotherapy: an exploratory analysis from the Sertraline vs. Electrical Current Therapy for Treating Depression Clinical Study.
    Brunoni AR; Júnior RF; Kemp AH; Lotufo PA; Benseñor IM; Fregni F
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):53-61. PubMed ID: 24060107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: Results from the SELECT-TDCS trial.
    Brunoni AR; Machado-Vieira R; Sampaio-Junior B; Vieira EL; Valiengo L; Benseñor IM; Lotufo PA; Carvalho AF; Cho HJ; Gattaz WF; Teixeira AL
    J Affect Disord; 2015 Oct; 185():209-13. PubMed ID: 26241865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcranial direct current stimulation for the treatment of major depressive disorder: A meta-analysis of randomized controlled trials.
    Wang Y
    Psychiatry Res; 2019 Jun; 276():186-190. PubMed ID: 31100509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed effect of bifrontal transcranial direct current stimulation in patients with treatment-resistant depression: a pilot study.
    Li MS; Du XD; Chu HC; Liao YY; Pan W; Li Z; Hung GC
    BMC Psychiatry; 2019 Jun; 19(1):180. PubMed ID: 31185966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder.
    Kamijima K; Kimura M; Kuwahara K; Kitayama Y; Tadori Y
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):591-601. PubMed ID: 29660207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial.
    McClintock SM; Martin DM; Lisanby SH; Alonzo A; McDonald WM; Aaronson ST; Husain MM; O'Reardon JP; Weickert CS; Mohan A; Loo CK
    Depress Anxiety; 2020 Mar; 37(3):261-272. PubMed ID: 31944487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the efficacy of a 5-day course of transcranial direct current stimulation (TDCS) on depression and memory function in patients with well-controlled temporal lobe epilepsy.
    Liu A; Bryant A; Jefferson A; Friedman D; Minhas P; Barnard S; Barr W; Thesen T; O'Connor M; Shafi M; Herman S; Devinsky O; Pascual-Leone A; Schachter S
    Epilepsy Behav; 2016 Feb; 55():11-20. PubMed ID: 26720704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcranial direct current stimulation for the treatment of post-stroke depression: results from a randomised, sham-controlled, double-blinded trial.
    Valiengo LC; Goulart AC; de Oliveira JF; Benseñor IM; Lotufo PA; Brunoni AR
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):170-175. PubMed ID: 27815324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcranial Direct Current Stimulation for Treatment-Resistant Major Depression: A Double-Blind Randomized Sham-Controlled Trial.
    Sharafi E; Taghva A; Arbabi M; Dadarkhah A; Ghaderi J
    Clin EEG Neurosci; 2019 Nov; 50(6):375-382. PubMed ID: 31304775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sertraline vs. ELectrical Current Therapy for Treating Depression Clinical Trial--SELECT TDCS: design, rationale and objectives.
    Brunoni AR; Valiengo L; Baccaro A; Zanao TA; de Oliveira JF; Vieira GP; Bueno VF; Goulart AC; Boggio PS; Lotufo PA; Bensenor IM; Fregni F
    Contemp Clin Trials; 2011 Jan; 32(1):90-8. PubMed ID: 20854930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    ; Davidson JR; Gadde KM; Fairbank JA; Krishnan KRR; Califf RM; Binanay C; Parker CB; Pugh N; Hartwell TD; Vitiello B; Ritz L; Severe J; Cole JO; de Battista C; Doraiswamy PM; Feighner JP; Keck P; Kelsey J; Lin KM; Londborg PD; Nemeroff CB; Schatzberg AF; Sheehan DV; Srivastava RK; Taylor L; Trivedi MH; Weisler RH
    JAMA; 2002 Apr; 287(14):1807-14. PubMed ID: 11939866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heart rate variability is a trait marker of major depressive disorder: evidence from the sertraline vs. electric current therapy to treat depression clinical study.
    Brunoni AR; Kemp AH; Dantas EM; Goulart AC; Nunes MA; Boggio PS; Mill JG; Lotufo PA; Fregni F; Benseñor IM
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):1937-49. PubMed ID: 23759172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.